Plain-English translation of NCT06316895 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether ultrasound-guided thermal ablation—a minimally invasive heat treatment—works as well as traditional thyroid surgery for treating small papillary thyroid cancers that haven't spread beyond the thyroid. Researchers are also developing an artificial intelligence tool to help predict which patients will have the best outcomes with this heat treatment. The study will follow nearly 4,000 patients to compare how well each approach works.
Traditional thyroid surgery can be effective but carries risks like voice changes and complications from removing the entire gland. This trial explores whether heat treatment—which is less invasive and preserves more of the thyroid—could be a safer alternative for patients with early-stage, low-risk thyroid cancer.
You likely qualify if…
You likely don't qualify if…
You will choose either heat treatment guided by ultrasound or traditional thyroid surgery, depending on what you and your doctor decide is best for you. After treatment, you'll have regular follow-up visits and imaging scans for at least 12 months to monitor how well the treatment worked and watch for any side effects. Researchers will also use your medical information to help develop an artificial intelligence tool that can predict treatment outcomes for future patients.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China
Sponsor
Chinese PLA General Hospital
Enrollment target
~3,772 participants
Started
April 2024
Primary completion
April 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lin Yan, MD
Chinese PLA General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.